Urine Testing Devices Market Scope
Urine testing device is a device used in the clinical setting to perform automatic urine testing. It can detect and quantify a number of analytics including bilirubin, protein, glucose and red blood cells. Testing of the urine is known as urinalysis. Urine testing is perform to detect the substances or cells in the urine that point to different disorders. It is used to diagnose disease.
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Urine Testing Devices market throughout the predicted period.
AVE Science & Technology Co.Ltd. (China), Roche Holding AG (Switzerland), Sysmex Corporation (Japan), ARKRAY Healthcare Pvt. Ltd (India), Siemens AG (Germany), Express Diagnostics International Inc. (United States), Beckman Coulter (United States), Alere, Inc. (United States), Dragerwerk AG & Co. KGaA (Germany) and LabCorp (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
The study have segmented the market of Global Urine Testing Devices market , by Application (Hospitals, Diagnostics Laboratories, Research Institute and Others) and Region with country level break-up.
On the basis of geography, the market of Urine Testing Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
Recently Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD), a global supplier of diagnostics tests. The acquisition of FTD increases the menu of the Siemens Healthineers VERSANT kPCR Molecular System by over 80 assays and syndromic panels, transforming care delivery for its customers with a comprehensive solution for molecular testing of infectious diseases.
Market Trend
- Demand for Urine Testing Devices with Improved Features
Market Drivers
- Rising Prevalence of Kidney Diseases and Urinary Tract Infections
- Technological Innovations in the Urine Testing
Opportunities
- Growing Medicinal Awareness among People
- Increase in Geriatric Population
Restraints
- Lack of Awareness about Devices
Challenges
- Stringent Rules and Regulations of the Government
Key Target Audience
Urine Testing Device Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End user